As news broke of a successful trial of Pfizer and BioNTech’s vaccine on Monday morning, the reaction of epidemiologists and virologists came pouring in. Reader, they’re excited. Always a cautious bunch, scientists—so far, reaction skews European and U.K. heavy as the U.S. wakes up to the news—measured their words, but some, like Cambridge University’s Gordon […]